BSE MidCap Select News and Updates

Name: Latest research reports of Lupin Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Lupin Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Keep track of all breaking news on BSE MidCap Select from all sources in a single place.

Load latest

Bharat Forge Ltd.

03 Jul 2025

1281.10

-1.92%

North American Class 8 Truck Orders Fall To 16-Year Low In June; Bharat Forge, MM Forgings In Focus

NDTV Profit

North American Class 8 Truck orders for June were well below the 10-year monthly average of 19,213.

Bharat Forge Ltd.'s price crossed below 30Day SMA today

Bharat Forge Ltd.

03 Jul 2025

1281.10

-1.92%

Bharat Forge Dividend: Last Day To Buy Shares To Qualify Details Here

NDTV Profit

Bharat Forge's board announced a final dividend of Rs 6 per share of the face value of Rs 2 each for the financial year ended March 31, 2025.

Bharat Forge Ltd. is trading below its 30 day SMA of 1292.8

Bharat Forge acquires AAM India Manufacturing for 746.46 crore

Business Standard | 02 Jul 2025 1 more

Lupin Ltd.

03 Jul 2025

1922.10

-2.86%

Lupin (BUY): Lupin carves out Consumer Healthcare business

Buy: Lupin Ltd.

BOB Capital Markets Ltd.

LPC's OTC carve-out won't significantly impact financials, but aims to double OTC sales by sharpening focus

Number of FII/FPI investors increased from 964 to 979 in Mar 2025 qtr.

Au Small Finance Bank Ltd.

02 Jul 2025

819.85

0.74%

AU Small Finance Bank Appoints Two Independent Directors, Senior Executives

NDTV Profit

Besides, the bank has appointed Yogesh Jain as chief operating officer, Vivek Tripathi as chief credit officer and Dhavan Shah as head (commercial banking).

Au Small Finance Bank Ltd. is trading above all available SMAs

AU Small Finance Bank Appoints New Directors, Sets Mumbai As Growth Hub

NDTV Profit | 02 Jul 2025

Au Small Finance Bank Ltd.

02 Jul 2025

819.85

0.74%

AU Small Finance Bank appoints two independent directors, senior executives

Business Standard

AU Small Finance Bank on Wednesday said it has appointed two independent directors and a number of senior executives across verticals. The two independent directors are Nandkumar Saravade - a former IPS officer and an expert in cyber security, fraud risk and regulatory technology- and Jagajit Mangal Prasad, having an experience of over three decades in human capital strategy. Besides, the bank has appointed Yogesh Jain as Chief Operating Officer, Vivek Tripathi as Chief Credit Officer and Dhavan Shah as Head (Commercial Banking). Avinash Sharan has been elevated to Head (Branch Banking) and Arvind Butola as National Business Head (Credit Cards & Unsecured Loans), the bank said in a statement. "New appointments and our senior leaders stepping into enhanced roles, reflecting our readiness to serve a more diverse India, to manage scale with sustainability, and to create enduring value through 'samajhdaari', 'imaandaari' and 'zimmedaari'," Sanjay Agarwal , Founder, MD & CEO, AU...

Au Small Finance Bank Ltd. has gained 44.73% in the last 6 Months

IDFC First Bank Ltd.

02 Jul 2025

77.86

0.19%

Axis Punch:IDFC First Bank

Buy: IDFC First Bank Ltd.

Recommendation Target

Axis Direct

We recommend a BUY on the stock with a target price of Rs 85/share, implying an upside of 10% from the CMP

IDFC First Bank Ltd. is trading above all available SMAs

Lupin Ltd.

01 Jul 2025

1922.10

-2.86%

Lupin carves out consumer healthcare biz into wholly owned subsidiary

Business Standard

The carve-out will be effective from 1 July 2025, according to the company's regulatory filing on the exchanges.

Lupin Ltd. is trading below all available SMAs

Drugmaker Lupin creates a separate entity for its consumer healthcare business

Business Line | 01 Jul 2025 1 more

Dixon Technologies (India) Ltd.

01 Jul 2025

15473.00

0.26%

Morgan Stanley downgrades Dixon Tech to 'Underweight'; share price falls 3%

Business Standard

Dixon Technologies' share price came under pressure today after global brokerage Morgan Stanley downgraded the stock to 'Underweight,' even as it raised the target price to 11,563 per share.

Number of FII/FPI investors increased from 838 to 885 in Mar 2025 qtr.

Torrent Pharmaceuticals Ltd.

01 Jul 2025

3322.40

-0.89%

Torrent Pharma Target Price Hiked By BofA On Likely Margin Synergies After JB Deal

NDTV Profit

BofA's new target for Torrent Pharma stock implies a return potential of 2.7% over the previous close.

Torrent Pharmaceuticals Ltd. is trading above all available SMAs

Torrent Pharma said to get $2.3 billion credit line for JB buy

Business Line | 30 Jun 2025 5 more

Torrent Pharmaceuticals Ltd.

01 Jul 2025

3322.40

-0.89%

Torrent Pharmaceuticals (TRP IN) Event Update Acquires JB...

Accumulate: Torrent Pharmaceuticals Ltd.

Target

Prabhudas Lilladhar

chronic therapies and opens up many newer therapeutic areas. The deal also adds JBCP's CDMO vertical, offering diversification and growth optionality. The acquisition is likely to be debt-funded requiring Rs 122bn to fund acquisition upfront. We see JBCP current OPM of 2728% to scale to 31-32% (similar to current TRP margins) via sourcing efficiencies, cost rationalization, and pricing actions on keys brands. Historically TRP have managed to integrate...

Torrent Pharmaceuticals Ltd. is trading above all available SMAs

Is BSE MidCap Select worth buying?

12 Votes:

Buy 75.0%

Sell 16.67%

Hold 8.33%

BSE MidCap Select PB	5.7
BSE MidCap Select PE	41.5
BSE MidCap Select DIV	0.5
BSE MidCap Select EPS	412.3